Edap Tms (NASDAQ:EDAP) Receives “Hold” Rating from Jefferies Financial Group

Edap Tms (NASDAQ:EDAP)‘s stock had its “hold” rating reissued by Jefferies Financial Group in a research report issued on Friday, Marketbeat reports. They currently have a $2.00 target price on the medical equipment provider’s stock, down from their previous target price of $8.00. Jefferies Financial Group’s target price indicates a potential upside of 24.22% from the company’s current price.

Several other brokerages have also issued reports on EDAP. Piper Sandler cut their price target on Edap Tms from $5.00 to $4.50 and set an “overweight” rating on the stock in a research note on Friday, March 28th. HC Wainwright restated a “buy” rating and set a $19.00 target price on shares of Edap Tms in a research report on Friday, March 28th. Finally, StockNews.com assumed coverage on shares of Edap Tms in a research report on Friday, March 28th. They set a “hold” rating for the company.

Edap Tms Trading Down 15.7 %

EDAP opened at $1.61 on Friday. Edap Tms has a 1-year low of $1.51 and a 1-year high of $8.50. The stock has a market capitalization of $59.74 million, a PE ratio of -2.48 and a beta of 0.37. The company has a current ratio of 2.18, a quick ratio of 1.46 and a debt-to-equity ratio of 0.08. The firm has a 50-day moving average price of $2.39 and a two-hundred day moving average price of $2.45.

Edap Tms (NASDAQ:EDAP) last issued its quarterly earnings results on Thursday, March 27th. The medical equipment provider reported ($0.05) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.11) by $0.06. Edap Tms had a negative net margin of 34.92% and a negative return on equity of 44.21%. The business had revenue of $22.69 million during the quarter, compared to analyst estimates of $20.83 million. As a group, equities analysts anticipate that Edap Tms will post -0.6 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Edap Tms

Hedge funds have recently added to or reduced their stakes in the stock. Illumine Investment Management LLC acquired a new position in shares of Edap Tms during the 4th quarter worth about $50,000. BNP Paribas Financial Markets boosted its stake in Edap Tms by 23.7% during the 3rd quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider’s stock worth $59,000 after acquiring an additional 4,400 shares during the last quarter. Jane Street Group LLC grew its holdings in Edap Tms by 174.7% during the fourth quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider’s stock valued at $69,000 after purchasing an additional 73,361 shares during the period. Millennium Management LLC increased its stake in Edap Tms by 218.5% in the fourth quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider’s stock valued at $108,000 after purchasing an additional 33,558 shares in the last quarter. Finally, Orion Capital Management LLC raised its holdings in Edap Tms by 10.4% in the third quarter. Orion Capital Management LLC now owns 69,800 shares of the medical equipment provider’s stock worth $178,000 after purchasing an additional 6,600 shares during the period. Institutional investors and hedge funds own 62.74% of the company’s stock.

About Edap Tms

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.